(1) Subject to the limitation in (2), if a local health officer receives information about a case of any of the following diseases, the officer must work with the department to ensure that a specimen from the case is submitted to the department, when possible, which will be analyzed to confirm the existence or absence of the disease in question, or for further examination associated with surveillance or investigation of disease transmission:

(a) Anthrax;

(b) Arboviral diseases, neuroinvasive and non-neuroinvasive (California serogroup, Chikungunya, Eastern equine encephalitis, Powassan, Saint Louis encephalitis, West Nile virus, Western equine encephalitis, Zika virus infection);

(c) Botulism;

(d) Brucellosis;

(e) Candida auris (C. auris);

(f) Carbapenem-Resistant Organisms;

(g) Cholera;

(h) Diphtheria;

(i) Escherichia coli, Shiga toxin-producing (STEC);

(j) Haemophilus influenzae invasive disease;

(k) Hantavirus pulmonary syndrome or infection;

(l) Influenza;

(m) Listeriosis;

(n) Measles (rubeola);

(o) Meningococcal disease (Neisseria meningitidis);

(p) Plague;

(q) Poliomyelitis, paralytic or non-paralytic;

(r) Rabies (human);

(s) Rubella (including congenital);

(t) Salmonellosis (including Salmonella Typhi and Paratyphi);

(u) Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) disease;

(v) Shigellosis;

(w) Smallpox;

(x) Trichinellosis (Trichinosis);

(y) Tuberculosis disease;

(z) Tularemia;

(aa) Vancomycin-intermediate staphylococcus aureus (VISA);

(ab) Vancomycin-resistant staphylococcus aureus (VRSA); and

(ac) Vibriosis.

(2) In the event of an outbreak, emergence of a communicable disease or a disease of public health importance, specimens must be submitted at the request of the department until a representative sample has been reached as determined by the department. 

(3) A laboratory professional or any other person in possession of a specimen from a case of a disease listed in (1) must submit the specimen to the department upon request.

(4) If no specimen from the case is otherwise available and the case refuses to allow a specimen to be taken for purposes of (1), the case will be assumed to be infected and must comply with whatever control measures are imposed by the department, or the local health officer.


History: 50-1-202, 50-1-204, MCA; IMP, 50-1-202, 50-1-204, MCA; NEW, 1987 MAR p. 2147, Eff. 11/28/87; AMD, 1994 MAR p. 1295, Eff. 5/13/94; AMD, 1995 MAR p. 1127, Eff. 6/30/95; AMD, 2000 MAR p. 2528, Eff. 9/22/00; TRANS, from DHES, 2002 MAR p. 913; AMD, 2006 MAR p. 2112, Eff. 9/8/06; AMD, 2013 MAR p. 967, Eff. 6/7/13; AMD, 2017 MAR p. 343, Eff. 3/25/17; AMD, 2019 MAR p. 1745, Eff. 1/1/20.